International Private Wealth Advisors LLC Makes New Investment in Cardinal Health, Inc. $CAH

International Private Wealth Advisors LLC bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 1,825 shares of the company’s stock, valued at approximately $406,000.

A number of other hedge funds also recently modified their holdings of CAH. BlackRock Inc. bought a new stake in Cardinal Health during the second quarter worth about $6,293,115,000. Wellington Management Group LLP grew its stake in Cardinal Health by 247.5% during the second quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company’s stock worth $3,530,206,000 after buying an additional 10,584,119 shares in the last quarter. Bank of America Corp DE bought a new position in Cardinal Health in the 2nd quarter valued at about $689,066,000. Legal & General Group Plc bought a new position in Cardinal Health in the 2nd quarter valued at about $438,870,000. Finally, Pacer Advisors Inc. raised its position in shares of Cardinal Health by 14.7% in the 1st quarter. Pacer Advisors Inc. now owns 1,565,131 shares of the company’s stock valued at $330,728,000 after buying an additional 200,021 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.3%

CAH stock opened at $277.63 on Thursday. The stock has a market capitalization of $64.17 billion, a P/E ratio of 35.92, a price-to-earnings-growth ratio of 2.12 and a beta of 0.53. Cardinal Health, Inc. has a 12 month low of $180.45 and a 12 month high of $286.29. The firm has a 50-day moving average price of $242.85 and a 200-day moving average price of $224.57.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, November 5th. The company reported $3.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.94 by $0.32. The company had revenue of $67.51 billion for the quarter, compared to analyst estimates of $66.67 billion. Cardinal Health had a net margin of 0.71% and a negative return on equity of 102.72%. The firm’s revenue was up 5.5% on a year-over-year basis. During the same period in the previous year, the firm posted $2.55 EPS. As a group, equities analysts predict that Cardinal Health, Inc. will post 12.96 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 15th. Shareholders of record on Monday, January 4th will be given a $0.5158 dividend. The ex-dividend date is Monday, January 4th. This represents a $2.06 dividend on an annualized basis and a yield of 0.7%. Cardinal Health’s dividend payout ratio (DPR) is currently 26.65%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on CAH. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, October 25th. Robert W. Baird lifted their price objective on shares of Cardinal Health from $251.00 to $274.00 and gave the company an “outperform” rating in a research note on Wednesday, August 12th. Leerink Partners set a $292.00 price objective on shares of Cardinal Health in a research note on Tuesday, August 11th. Wells Fargo & Company boosted their price objective on shares of Cardinal Health from $245.00 to $277.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Finally, Evercore reiterated an “outperform” rating and issued a $270.00 price target on shares of Cardinal Health in a research note on Wednesday, August 12th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $275.62.

Insider Transactions at Cardinal Health

In other news, CAO Mary C. Scherer sold 2,302 shares of the stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $237.39, for a total value of $546,471.78. Following the completion of the transaction, the chief accounting officer directly owned 2,811 shares in the company, valued at approximately $667,303.29. This represents a 45.02% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Deborah Weitzman sold 7,354 shares of the firm’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $235.45, for a total value of $1,731,499.30. Following the sale, the chief executive officer directly owned 77,901 shares in the company, valued at approximately $18,341,790.45. This trade represents a 8.63% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 210,271 shares of company stock valued at $49,626,657. Corporate insiders own 0.12% of the company’s stock.

Recent Cardinal Health Headlines

These are some of the CAH headlines that stood out recently:

• Positive Sentiment: Cardinal Health approved a quarterly dividend of $0.5158 per share, payable January 15, 2027, to shareholders of record on January 4. The declaration provides continued income for shareholders, though the article does not offer a new outlook on dividend growth. Cardinal Health Board of Directors Approves Quarterly Dividend
• Positive Sentiment: Zacks highlighted CAH’s momentum and growth characteristics, while a separate screen included the company among stocks with strong interest coverage and financial resilience. These are supportive assessments, not new company announcements. Zacks Cardinal Health Momentum Stock Article
• Neutral Sentiment: Other coverage asks whether the dividend is safe and whether the company can repeat its past performance; the headlines alone do not provide new financial results or a clear change in outlook. Is Cardinal Health’s Dividend Safe? Can Cardinal Health Stock Repeat Its Last Five Years?

Cardinal Health Profile

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.